Atropos Health
@atroposhealth
Atropos Health is the developer of the first physician consultation service powered by publication-grade real-world evidence.
ID: 1520031737379799046
http://atroposhealth.com 29-04-2022 13:26:35
163 Tweet
220 Takipçi
83 Takip Edilen
Today we announce $33 million in Series B funding to further increase access to real-world evidence for decision-making in healthcare with @Valtruis Cencora @McK_Ventures and Merck Healthcare Jim Breyer Emerson Collective Presidio Ventures. hubs.li/Q02yfYtb0
#AtroposHealth joins real-world evidence and AI to close the evidence gap in healthcare. "The same also accelerates everything pharma is doing," said CEO and co-Founder Dr. Brigham Hyde. More from @heatherlandi: hubs.li/Q02yjJC50
Great event #DHISEAST! #AtroposHealth co-Founder and CEO Dr. Brigham Hyde with Carrie Williams, McKesson Ventures Lynne Nowak Surescripts and facilitator Ian Chiang Flare Capital. Learn more about how Atropos Health supports Life Sciences: hubs.li/Q02B0BNm0
Join us July 10, 2024 at AWS Summit NY. Atropos Health CEO and co-founder Dr. Brigham Hyde is speaking on “How Generative AI is transforming Healthcare and Life Sciences” with Samantha Perrone @AWScloud, Imran Qureshi b.well Connected Health and Karim Galil @Mendel_AI_ hubs.li/Q02FYd6H0
Join us LIVE at AWS Summit NY. Atropos Health CEO and co-founder Dr. Brigham Hyde with Samantha Perrone @AWScloud, Imran Qureshi b.well Connected Health and Karim Galil @Mendel_AI_ hubs.li/Q02G2pMy0 Session begins at 12:25 PM Eastern
Watch this interview of #AtroposHealth Chief Medical Officer and co-founder Saurabh Gombar as he discusses our recent study of Large Language Models (#LLM) for healthcare use, including ChatRWD™ . Thanks to Jessica Hagen at @HIMSSTV for hosting! hubs.li/Q02Gvyhh0
The shift from convenience to trust is becoming increasingly important in healthcare. #AtroposHealth CEO and co-founder Dr Brigham Hyde shared how ChatRWD™ outperformed industry heavyweights like ChatGPT-4 with Brian Buntz @DrugDiscovDev hubs.li/Q02Jwx3-0
When a recent JAMA Ophthalmology study linked semaglutide to an increased risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), Dr. David Klonoff asked #AtroposHealth & published: "RWE Assessment of the Risk of NAION in Patients Prescribed Semaglutide" hubs.li/Q02JQQ_z0
CEO and co-founder of #AtroposHealth Dr. Brigham Hyde shared his business insights and strategies to navigate the funding landscape in a post-COVID world with Jessica Hagen. It's all about creating lasting impact in the market. The full conversation: hubs.li/Q02LwmwP0
Are prophylactic antibiotics necessary before thyroid surgery? Saurabh Gombar #AtroposHealth Chief Medical Officer and co-founder published a study using Real World Evidence on the association between antibiotic prophylaxis and surgical site infections: hubs.li/Q02MnRrx0
#AtroposHealth CEO and co-founder Dr. Brigham Hyde will answer the question, "How is Pharma Leveraging AI?" on a panel hosted by Katie Adams from @Medcitynews. Read how Atropos Health's generative AI solution, ChatRWD™ outperformed other LLMs: hubs.li/Q02Qfcx90